TipRanks
Monopar Therapeutics Inc (DE:1IY0)
FRANKFURT:1IY0
Germany Market
1IY0
Monopar Therapeutics Inc
RESEARCH TOOLSreports

Monopar Therapeutics Inc (1IY0) Income Statement

0 Followers

Monopar Therapeutics Inc Income Statement

Last quarter (Q2 2026), Monopar Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Monopar Therapeutics Inc's net income was $-5.31M. See Monopar Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.70M$ 16.16M$ 8.83M$ 10.54M$ 9.13M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Operating Income
$ -16.70M$ -16.16M$ -8.83M$ -10.54M$ -9.13M
Other Income/Expenses
$ 2.99M$ 575.30K$ 429.04K$ 21.24K$ 24.02K
Pretax Income
$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Net Income
$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Per Share Metrics
Basic EPS
$ -1.85$ -1.36$ -0.58$ -0.83$ -0.73
Diluted EPS
$ -1.85$ -1.36$ -0.58$ -0.83$ -0.73
Weighted Average Shares Outstanding
 7.41M 11.44M 14.51M 12.72M 12.47M
Weighted Average Shares Outstanding (Diluted)
 7.41M 11.48M 14.51M 12.72M 12.47M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History